+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Attention Deficit Hyperactivity Disorder"

Mental Health Application: Technologies and Global Markets - Product Thumbnail Image

Mental Health Application: Technologies and Global Markets

  • Report
  • September 2023
  • 115 Pages
  • Global
From
From
From
Behavioral Health Market in US 2023-2027 - Product Thumbnail Image

Behavioral Health Market in US 2023-2027

  • Report
  • October 2023
  • 142 Pages
  • United States
From
From
From
From
From
Complete Mental Health Resource Guide, 2022/23 - Product Thumbnail Image

Complete Mental Health Resource Guide, 2022/23

  • Book
  • June 2022
  • 800 Pages
From
From
Dealing with OCD in the Office - Webinar (Recorded) - Product Thumbnail Image

Dealing with OCD in the Office - Webinar (Recorded)

  • Webinar
  • July 2021
  • 60 Minutes
  • Global
From
Loading Indicator

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health disorder characterized by difficulty paying attention, hyperactivity, and impulsivity. It is most commonly diagnosed in children, but can persist into adulthood. Treatment for ADHD typically includes medication, psychotherapy, and lifestyle changes. The ADHD market is a subset of the larger mental health market, which is estimated to be worth billions of dollars. The ADHD market is expected to grow in the coming years due to increased awareness and diagnosis of the disorder. Several companies are involved in the ADHD market, including pharmaceutical companies that produce medications for the disorder, as well as companies that provide psychotherapy and lifestyle interventions. Examples of these companies include Shire, Novartis, and Otsuka Pharmaceuticals. Show Less Read more